Cipla Ltd.

Cipla has received shareholders’ approval to raise up to Rs 3,000 crore through issuance of equity shares or other securities convertible into equity shares. Earlier, the company's board had approved raising funds up to Rs 3,000 crore.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.